CELLTRION PORTUGAL, UNIPESSOAL LDA secures contract for Infliximab 100 Mg (Biosimilar) Remsima Powder Conc Sol Inj Fr Iv

Portugal, Jan. 13 -- Portugal based CELLTRION PORTUGAL, UNIPESSOAL LDA has secured contract from Unidade Local De Saude De Almada-Seixal, Epe for Infliximab 100 Mg (Biosimilar) Remsima Powder Conc Sol Inj Fr Iv. The value of the contract is worth 999600 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....